Revenue segments as reported by the company.

Net revenue, before excise taxes

Excise taxes

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Sales and marketing

Research and development

General and administrative

Restructuring costs

Share-based payments

Depreciation and amortization

Impairment loss on goodwill and indefinite-lived intangible assets

Impairment loss on long-lived assets

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Cronos Group

Cronos Group, Inc. engages in the production and distribution of cannabis. Its brands include PEACE NATURALS, COVE, Spinach, Lord Jones, and PEACE+. The company was founded by Lorne Michael Gertner and Paul Rosen on August 21, 2012 and is headquartered in Toronto, Canada.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Cronos Group, Inc. engages in the production and distribution of cannabis. I It operates through the Canada and Israel segments. The company was founded on August 21, 2012 and is headquartered in Toronto, Canada.

Cronos has delayed its quarterly and annual earnings report by at least two weeks while it conducts an audit of its financials. Until that audit is complete, the stock will likely underperform.

Cronos Stock Just Raised a Massive Red Flag

General Motors

The stock market had another huge move, this time upward.

Stock Market Wrap-Up: GM Fights Tesla, Cronos Smokes Higher

Investors reacted positively to an analyst upgrade.

Why Cronos Group Stock Crushed It Today

Aurora Cannabis

Aphria

Concerns over the global supply chain weighed on these top pot stocks last month.

Why Aphria, Aurora Cannabis, and Cronos Group Sank in February

It may take awhile for it to materialize, but beaten-up Cronos stock could eventually turn into a multi-bagger for investors.
The post Patience Will Be Rewarded for Investors in Beaten-Up Cronos Stock appeared first on InvestorPlace.

Patience Will Be Rewarded for Investors in Beaten-Up Cronos Stock

Tesla

SPDR Gold Trust

Tilray Brands

Tesla, Tilray, Cronos Group and the gold ETF (GLD) were our top stock trades for Wednesday. That said, here's a look at the charts.

4 Top Stock Trades for Wednesday: TSLA, TLRY, GLD, CRON

Investors worried over uncertainty about when the company will file its annual report and disappointing Q4 results for one of its peers.

Why Cronos Group Shares Sank Today

The bullish case for Cronos Group Inc (NASDAQ: CRON)(TSX:CRON) has come to an end after the company requested an extension to its earnings release, according to Stifel.

Stifel's Buzz With Cronos Group Comes To An End

It makes sense to keep an eye on Aurora Cannabis and two others this month.

3 Top Marijuana Stocks to Watch in March

The company also provided an explanation as to why it's delayed reporting.

Cronos Group Commits to Releasing Q4 Results in March

Cronos Group Inc. CRON, +2.91% CRON, +2.57% said late Monday that it was unable to complete its financial statements for fiscal 2019 because of an ongoing review by an internal audit committee, outside lawyers and forensic accountants, according to a filing with the Securities and Exchange Commission.

Cronos unable to complete annual report due to internal review

HEXO Corp

Worries about the global supply chain are sinking these five Canadian pot stocks today.

Why Aurora Cannabis, Cronos Group, HEXO, OrganiGram Holdings, and Tilray Are Getting Hammered Today

OrganiGram Holdings Inc.

Aphria, Cronos Group, and OrganiGram Holdings are all screaming bargains relative to their long-term outlook.

Why I Bought These 3 Ridiculously Cheap Pot Stocks

It's now anybody's guess when the figures will be published.

Cronos Group Delays Q4 Results Release

Why marijuana stocks are tanking Monday may be a bit counterintuitive. After all, with major U.S.

Why Cronos and Tilray Have Crumbled

That Q4 update planned for later this week? It's not happening.

Why Cronos Group Stock Is Tumbling Today

Investors will focus on Cronos' (CRON) regular top- and bottom-line numbers, along with its pipeline progress, when it reports Q4 results.

Cronos (CRON) to Report Q4 Earnings: What's in the Cards?

Canopy Growth

These stocks hold the promise of long-term benefits despite the current market downturn for cannabis.

5 Best Cannabis Stocks to Own for the Next Decade

Canadian cannabis company Cronos Group Inc. CRON, -2.59% CRON, -2.88% said Monday it is delaying the release of fourth-quarter earnings that were previously scheduled for Thursday.

Cronos to delay release of fourth-quarter earnings that were due on Thursday

Nasdaq

New Leaf Data Services is compiling the numbers from cannabis business entities in Canada.

Nasdaq Adds Marijuana Price Indexes to Its Platform

Despite their miserable performance, marijuana stocks were in high demand by asset managers in Q4.

Surprise! Billionaire Money Managers Bought These 4 Pot Stocks in the Fourth Quarter

In the latest trading session, Cronos Group (CRON) closed at $7.29, marking a +1.11% move from the previous day.

Cronos Group (CRON) Outpaces Stock Market Gains: What You Should Know

Amplify Alternative Harvest ETF

Here's why cannabis stocks may have bottomed out. Gain exposure through these two leading pot companies or a marijuana-themed ETF.

Cannabis Stocks Appear Ready to Test Recent Highs

Cronos Group reports its fourth-quarter and full-year results on Feb. 27. Owners of CRON stock shouldn’t expect much in the near term.

2020 Could Be the Year Cronos Comes Alive

Altria

Constellation Brands

Brand-name companies are finding little early-stage success in the high-growth cannabis industry.

News for Cronos Group Stock (CRON)